Di Brizzi EV, Buononato D, Benvenuto P, et al. Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis. Dermatol Pract Concept. 2023;13(4):e2023215. doi:10.5826/dpc.1304a215